MANNKIND CORP Net Cash Provided by (Used in) Investing Activities, Continuing Operations
MANNKIND CORP (MNKD) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $16.68 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-09
- MANNKIND CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $0.00.
- MANNKIND CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $0.00.
- MANNKIND CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $24.00K.
- MANNKIND CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $16.65M.
- MANNKIND CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $16.68M.
- MANNKIND CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$1.13M.
- MANNKIND CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$10.20M.
- MANNKIND CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$24.10M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 277 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 280 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 283 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $24.00K derived: sum of 3 quarters · filed 2018-02-27 | $16.68M 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $24.00K derived: sum of 2 quarters · filed 2017-11-07 | $16.68M 10-Q · filed 2017-11-07 | $16.68M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2017-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $16.68M 10-Q · filed 2017-08-07 | $16.68M derived: sum of 3 quarters · filed 2018-05-09 | $16.68M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2017-03-31 | $16.65M 10-Q · filed 2018-05-09 | $16.65M derived: sum of 2 quarters · filed 2018-05-09 | $16.65M derived: sum of 3 quarters · filed 2018-05-09 | $16.65M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | -$1.13M 10-K · filed 2018-02-27 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | -$1.13M 10-Q · filed 2017-11-07 | -$1.44M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$1.13M 10-Q · filed 2017-08-07 | -$1.44M derived: sum of 3 quarters · filed 2018-02-27 | -$2.59M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | -$1.13M 10-Q · filed 2017-05-10 | -$1.44M derived: sum of 2 quarters · filed 2018-02-27 | -$2.59M derived: sum of 3 quarters · filed 2018-02-27 | -$7.13M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | -$312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$1.47M derived: sum of 2 quarters · filed 2018-02-27 | -$6.00M derived: sum of 3 quarters · filed 2018-02-27 | -$10.20M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | -$5.69M derived: sum of 2 quarters · filed 2016-11-09 | -$9.89M 10-Q · filed 2016-11-09 | -$24.10M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | -$4.53M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2016-08-10 | -$8.74M 10-Q/A · filed 2016-08-10 | -$22.95M derived: sum of 3 quarters · filed 2017-03-16 | -$23.17M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | -$4.20M 10-Q · filed 2016-05-09 | -$18.42M derived: sum of 2 quarters · filed 2017-03-16 | -$18.63M derived: sum of 3 quarters · filed 2017-03-16 | -$26.89M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$14.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$14.43M derived: sum of 2 quarters · filed 2017-03-16 | -$22.69M derived: sum of 3 quarters · filed 2017-03-16 | -$24.10M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | -$217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$8.47M derived: sum of 2 quarters · filed 2015-11-09 | -$9.88M 10-Q · filed 2015-11-09 | -$16.05M derived: sum of 4 quarters · filed 2016-03-15 | -$345.55M 10-Q · filed 2014-11-10 | ||
| 2014-06-30 | -$8.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$9.67M 10-Q · filed 2015-08-10 | -$15.83M derived: sum of 3 quarters · filed 2016-03-15 | -$16.06M derived: sum of 4 quarters · filed 2016-03-15 | -$345.33M 10-Q · filed 2014-08-11 | ||
| 2014-03-31 | -$1.41M 10-Q · filed 2015-05-11 | -$7.58M derived: sum of 2 quarters · filed 2016-03-15 | -$7.80M derived: sum of 3 quarters · filed 2016-03-15 | -$7.94M derived: sum of 4 quarters · filed 2016-03-15 | -$337.07M 10-Q · filed 2014-05-12 | ||
| 2013-12-31 | -$6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$6.40M derived: sum of 2 quarters · filed 2016-03-15 | -$6.53M derived: sum of 3 quarters · filed 2016-03-15 | -$7.99M 10-K · filed 2016-03-15 | |||
| 2013-09-30 | -$230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$362.00K derived: sum of 2 quarters · filed 2014-11-10 | -$1.82M 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | -$132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$1.59M 10-Q · filed 2014-08-11 | |||||
| 2013-03-31 | -$1.46M 10-Q · filed 2014-05-12 | ||||||
| 2012-12-31 | -$560.00K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |